Literature DB >> 20952586

Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".

Philip F Stahel1, Michael A Flierl.   

Abstract

This Commentary discusses the role of inflammation after spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952586      PMCID: PMC2993273          DOI: 10.2353/ajpath.2010.100408

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

Review 1.  Regulation of the complement membrane attack pathway.

Authors:  B P Morgan
Journal:  Crit Rev Immunol       Date:  1999       Impact factor: 2.214

Review 2.  The central role of the alternative complement pathway in human disease.

Authors:  Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 3.  Repair of the injured spinal cord. A joint approach of basic and clinical research.

Authors:  Anita D Buchli; Eric Rouiller; Roland Mueller; Volker Dietz; Martin E Schwab
Journal:  Neurodegener Dis       Date:  2007       Impact factor: 2.977

4.  The role of the complement system in CNS inflammatory diseases.

Authors:  Philip F Stahel; Scott R Barnum
Journal:  Expert Rev Clin Immunol       Date:  2006-05       Impact factor: 4.473

5.  Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.

Authors:  Fei Qiao; Carl Atkinson; Hongbin Song; Ravinder Pannu; Inderjit Singh; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 6.  Inflammation: beneficial or detrimental after spinal cord injury?

Authors:  Carmen C M Chan
Journal:  Recent Pat CNS Drug Discov       Date:  2008-11

7.  Complement elevation in spinal cord injury.

Authors:  J Rebhun; J Botvin
Journal:  Ann Allergy       Date:  1980-05

Review 8.  Advanced trauma life support, 8th edition, the evidence for change.

Authors:  John B Kortbeek; Saud A Al Turki; Jameel Ali; Jill A Antoine; Bertil Bouillon; Karen Brasel; Fred Brenneman; Peter R Brink; Karim Brohi; David Burris; Reginald A Burton; Will Chapleau; Wiliam Cioffi; Francisco De Salles Collet e Silva; Art Cooper; Jaime A Cortes; Vagn Eskesen; John Fildes; Subash Gautam; Russell L Gruen; Ron Gross; K S Hansen; Walter Henny; Michael J Hollands; Richard C Hunt; Jose M Jover Navalon; Christoph R Kaufmann; Peggy Knudson; Amy Koestner; Roman Kosir; Claus Falck Larsen; West Livaudais; Fred Luchette; Patrizio Mao; John H McVicker; Jay Wayne Meredith; Charles Mock; Newton Djin Mori; Charles Morrow; Steven N Parks; Pedro Moniz Pereira; Renato Sergio Pogetti; Jesper Ravn; Peter Rhee; Jeffrey P Salomone; Inger B Schipper; Patrick Schoettker; Martin A Schreiber; R Stephen Smith; Lars Bo Svendsen; Wa'el Taha; Mary van Wijngaarden-Stephens; Endre Varga; Eric J Voiglio; Daryl Williams; Robert J Winchell; Robert Winter
Journal:  J Trauma       Date:  2008-06

9.  Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.

Authors:  Nirmal K Banda; Brandt Levitt; Magdalena J Glogowska; Joshua M Thurman; Kazue Takahashi; Gregory L Stahl; Stephen Tomlinson; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

10.  Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.

Authors:  Iris Leinhase; V Michael Holers; Joshua M Thurman; Denise Harhausen; Oliver I Schmidt; Malte Pietzcker; Mohy E Taha; Daniel Rittirsch; Markus Huber-Lang; Wade R Smith; Peter A Ward; Philip F Stahel
Journal:  BMC Neurosci       Date:  2006-07-14       Impact factor: 3.288

View more
  3 in total

1.  Hyperbaric oxygen intervention reduces secondary spinal cord injury in rats via regulation of HMGB1/TLR4/NF-κB signaling pathway.

Authors:  Nan Kang; Yong Hai; Jing Yang; Fang Liang; Chun-Jin Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Treatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectives.

Authors:  Apostolia Tzekou; Michael G Fehlings
Journal:  J Clin Immunol       Date:  2014-04-11       Impact factor: 8.317

3.  Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.

Authors:  Diane Su; Mitra J Hooshmand; Manuel D Galvan; Rebecca A Nishi; Brian J Cummings; Aileen J Anderson
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.